おすすめの製品
由来生物
mouse
品質水準
抗体製品の状態
purified immunoglobulin
抗体製品タイプ
primary antibodies
クローン
NewE1, monoclonal
化学種の反応性
human
テクニック
activity assay: suitable
immunoprecipitation (IP): suitable
western blot: suitable
アイソタイプ
IgG1κ
NCBIアクセッション番号
UniProtアクセッション番号
輸送温度
dry ice
ターゲットの翻訳後修飾
unmodified
遺伝子情報
human ... CD226(10666)
詳細
CD226/DNAM1 is a T cell expressed plasma membrane receptor protein that plays multiple roles in lymphocyte signaling, intercellular adhesion, lymphokine secretion and cytotoxic T-cell and NK cell mediated killing. CD226 activates natural killer (NK) cell-mediated cytotoxicity and is a key player in the immune synapse between killer T cells and targets. Also, because it recognizes CD155 and nectins CD226/DNAM1 is being examined as a potential anti-cancer agent because soluble CD226 directly inhibits tumor growth by binding CD155 expressed on tumor cells and down regulating proliferation. CD226/DNAM-1 is expressed on Th1, but not Th2 or Th0 cells, it is also expressed on NK cells, CD8+ T-cells, but not developing T cells. CD226/DNAM-1 is also expressed on monocytes and platelets.
免疫原
Recombinant protein corresponding to human CD226/DNAM-1.
アプリケーション
Research Category
細胞骨格
細胞骨格
Research Sub Category
接着分子(CAM)
接着分子(CAM)
Activity Assay Analysis: A representative lot detected CD226/DNAM-1 which induces platelet activation and aggregation (Sherrington, P.D., et al. (1997). J. Biol. Chem. 272:21735-21744).
Immunoprecipitation Analysis: A representative lot immunoprecipitated CD226/DNAM-1 in isolated surface proteins from Jurkat and platelets (Sherrington, P.D., et al. (1997). J. Biol. Chem. 272:21735-21744).
MABT341 works by western blotting under both non-reducing and reducing conditions.
Immunoprecipitation Analysis: A representative lot immunoprecipitated CD226/DNAM-1 in isolated surface proteins from Jurkat and platelets (Sherrington, P.D., et al. (1997). J. Biol. Chem. 272:21735-21744).
MABT341 works by western blotting under both non-reducing and reducing conditions.
This Anti-CD226/DNAM-1 Antibody, clone NewE1 (Azide Free) is validated for use in Western Blotting and Immunoprecipitation and Activity Assay for the detection of CD226/DNAM-1.
品質
Evaluated by Western Blotting in CD226 Transfected CHO cell lysate.
Western Blotting Analysis: 1.0 µg/mL of this antibody detected CD226/DNAM-1 in 10 µg of CD226 Transfected CHO cell lysate.
Western Blotting Analysis: 1.0 µg/mL of this antibody detected CD226/DNAM-1 in 10 µg of CD226 Transfected CHO cell lysate.
ターゲットの説明
~39 kDa observed
物理的形状
Protein G Purified
Format: Purified
Purified mouse monoclonal IgG1κ in buffer containing PBS without preservatives.
保管および安定性
Stable for 1 year at -20°C from date of receipt.
Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
その他情報
Concentration: Please refer to lot specific datasheet.
免責事項
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our 製品選択ツール.
保管分類コード
12 - Non Combustible Liquids
WGK
WGK 2
引火点(°F)
Not applicable
引火点(℃)
Not applicable
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Jan Code
MABT341:
試験成績書(COA)
製品のロット番号・バッチ番号を入力して、試験成績書(COA) を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。
Cancer immunology research, 8(7), 912-925 (2020-04-09)
Clinical trials are evaluating the efficacy of anti-TIGIT for use as single-agent therapy or in combination with programmed death 1 (PD-1)/programmed death-ligand 1 blockade. How and whether a TIGIT blockade will synergize with immunotherapies is not clear. Here, we show
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)